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ABSTRACT 
Class switch recombination (CSR) and somatic hypermutation (SHM), occurring in the 
germinal center, are two important processes for B cell development. Both are initiated 
by activation-induced cytidine deaminase (AID), through deamination of the C residues 
in the variable and switch regions of the immunoglobulin locus, resulting in either in 
single stranded or double stranded DNA breaks. At least three pathways 
(nonhomologous end joining (NHEJ), base excision repair (BER), and mismatch repair 
(MMR)) have been implicated in processing, repair and ligation of the DNA breaks 
during CSR and SHM. However, the way in which these pathways are regulated and 
coordinated to mediate CSR and /or SHM is still not well understood. 
 
To explore the potential role of several proteins in CSR and SHM, including Ataxia-
telangiectasia and Rad3-related (ATR), Artemis, Cernunnos and the Mre11-Rad50-
NBS1 (MRN) complex, CSR junctions and SHM patterns in the immunoglobulin 
variable region gene were analyzed in patients with deficiency in these factors.  
 
We first studied the role of ATR during CSR and SHM. CSR junctions obtained from 
ATR deficiency (ATRD) patients showed significantly increased usage of 
microhomology, but impaired end joining with partially complementary (1-3 bp) DNA 
ends. The SHM pattern was also altered, with fewer mutations occurring at A but more 
at T residues, representing a loss of strand bias in targeting A/T pairs within certain 
hotspots. The function of ATR and ATM in CSR and SHM was also compared. Our 
data suggest that the role of ATR is partially overlapping with ATM, whereas ATR is 
also endowed with unique functional properties in the repair processes during CSR and 
SHM. 
 
We further studied the CSR junctions in Artemis deficient patients. A significantly 
increased usage of microhomology of ≥10 bp and an absolute absence of blunt-end 
joining were observed in S-S junctions in the patients. However, the S-S junctions 
obtained from a patient who carried “hypomorphic” mutations appeared to be largely 
normal in their usage of microhomology, although an unusual type of sequential 
switching was observed more frequently than expected. These findings suggest that 
varying modes of CSR junction resolution were used for different S regions, when the 
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function of Artemis is impaired. The altered pattern of CSR junctions also strongly link 
Artemis to the predominant NHEJ pathway during CSR. 
 
CSR junctions were also studied in B cells from Cernunnos deficient patients. These 
junctions were characterized by a significantly increased usage of microhomology of 
≥10 bp and a significantly decreased usage of “direct end joining”. This pattern has 
previously been observed in B cells deficient for DNA Ligase IV (Lig4), XRCC4, 
Artemis and ATM, suggesting that Cernunnos is likely to be involved in the DNA Lig4 
dependent NHEJ pathway during CSR.  
 
One somatically acquired missense mutation (p.Q227R) was also observed in the 
Cernunnos encoding gene in a germinal B cell like (GCB) diffuse large B cell 
lymphoma (DLBCL) sample. Two types of translocations (IGH/BCL2 and MYC/IGH) 
were detected in this tumor sample and one of the switch  regions appeared to be 
disrupted during translocation. Clonal-like, dynamic IgA switching activities were also 
observed, suggesting a link between defects in the Cernunnos dependent NHEJ 
pathway and aberrant CSR/switch translocations during the development of B cell 
malignancies. 
 
Mutations in Mre11 and NBS1 gene can cause Ataxia-telangiectasia-like disorder 
(ATLD) and Nijmegen breakage syndrome (NBS) respectively. SHM patterns in cells 
from these patients were furthermore analyzed. The frequency and distribution of 
mutations obtained from both patient groups were largely similar to that observed in 
controls. The mutation pattern from ATLD patients was only slightly changed, with a 
small increase of the frequency of A to C transversions, suggesting that Mre11 is 
unlikely to be the major nuclease involved in cleavage of the abasic sites during SHM. 
The mutation pattern from NBS patients was however, altered with a significantly 
increased number of G transversions (G→C and G→T), which mainly occurred in AID 
and/or SHM hotspot motifs. NBS1 might thus have a specific role in regulating the 
strand-biased repair during phase Ib mutagenesis.  
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1 INTRODUCTION  
 
1.1 DNA REPAIR 
About 1x104 to 1x106 DNA lesions occur in every human cell per day. These damages 
can be generated not only by endogenous agents, such as free radicals produced during 
metabolic processes, but also by exogenous agents such as UV light, ionizing radiation 
and industrial chemicals. Without repair, these damages may translate into mutations or 
other DNA structure alterations and eventually lead to cell death, or malignant 
transformation. To maintain genomic integrity, the DNA repair system is constantly 
active to respond to different forms of DNA damage.   
 
1.1.1 Single-strand break repair 
When one of the strands of a double helix is damaged, the other strand can be used as a 
template for repair. There are three major DNA repair mechanisms for single-strand 
breaks: base excision repair (BER), nucleotide excision (NER) and mismatch repair 
(MMR).   
 
The BER pathway usually removes and replaces a base lesion that has been generated 
by endogenous or exogenous agents. It is initiated by DNA glycosylases, which 
specifically recognize the modified base, cleaves the N- glycosidic bond and gives rise 
to an apurinic/apyrimidinic (AP) site (Demple and Sung, 2005; Tell et al., 2009; 
Wilson and Barsky, 2001). The abasic site is subsequently incised by an AP 
endonuclease, APE1. The 5′-deoxyribose phosphate strand break product is removed 
and the missing nucleotide gap is filled most frequently by DNA polymerase  (pol ) 
(Beard and Wilson, 2006). The remaining nick is sealed by a DNA ligase, which in 
mammals is typically ligase3(Lig3) in complex with the X-ray cross-
complementing protein 1 (XRCC1) (Ellenberger and Tomkinson, 2008).  
 
The NER pathway recognizes and removes large loops, bulky and helix-distorting 
lesions from DNA (Huang and Sancar, 1994). In contrast to BER, which only removes 
shorter patches of damaged DNA, NER can remove a total of 25-30 nucleotides. After 
DNA lesion recognition, the DNA is unwound and incised on either side of the aberrant 
base. DNA polymerases then fill the gap and DNA ligases (DNA Lig1 or Lig3) seal it. 
A large number of proteins are involved in the NER pathway such as the seven 
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xeroderma pigmentosum proteins (XPA – XPG), excision repair cross-complementing 
protein1 ( ERCC1), ERCC6, ERCC8, replication protein A (RPA) and transcription 
factor IIH (TFIIH) (Rouillon and White, 2011). 
 
MMR is a strand-specific DNA repair pathway, involved in the response to certain 
types of DNA damage, which recognizes and repairs base-base mismatches and 
insertion/deletion mispairs generated during DNA replication and recombination 
(Kolodner and Marsischky, 1999). Several human MMR proteins have been identified 
including MSH1-MSH6, MLH1, MLH3, postmeiotic segregation (PMS)1, PMS2, 
exonuclease 1 (Exo1), single-strand DNA-binding protein RPA, proliferating cellular 
nuclear antigen (PCNA), DNA polymerase δ (pol δ) and DNA Lig1 (Buermeyer et al., 
1999; Iyer et al., 2006). MSH proteins recognize DNA mismatches and bind to DNA, 
forming an active repair complex. MSH2/MSH6 complex binds base mispairs and 
small loop-outs, whereas MSH2/MSH3 does not bind base-mismatches but a wide 
range of loop-outs (Antony and Hingorani, 2003; Wu et al., 2003). Following mismatch 
recognition, MLH and PMS proteins such as MLH1/PMS2 bind to the MSH complex, 
recruit other potential downstream proteins with endonuclease and exonuclease 
activities and complete the repair process (Mazurek et al., 2002). 
 
1.1.2 Double-strand break repair  
DNA double-strand break (DSB), in which both strands in the double helix are 
damaged, is the most deleterious form of DNA damage. It can arise from oxidative 
stress, exposure to ionizing radiation and certain chemicals. DSBs are also 
intermediates in normal endogenous processes such as DNA replication, meiosis and 
immunoglobulin gene diversification including V(D)J recombination and class switch 
recombination (CSR) (Lieber and Karanjawala, 2004). Unrepaired or misrepaired 
DSBs may lead to genomic instability resulting in genetic aberrations or cell death. 
There are two major pathways to repair DSBs in eukaryotes: homologous 
recombination (HR) and nonhomologous end joining (NHEJ). 
 
1.1.2.1 Homologous recombination 
The HR repair pathway requires a long stretch of sequence homology and occurs 
during the late S/G2 phase of the cell cycle where the sister chromatids are located in 
close proximity (Sonoda et al., 2006). When a DSB occurs, the Mre11-Rad50-NBS1 
(MRN) complex can remove oligonucleotides from the 5′ prime and recruit Exo1and 
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Bloom syndrome protein (BLM) to the break site, making extensive resection, resulting 
in single-stranded DNA tails (Mimitou and Symington, 2009; Shim et al., 2010). 
Subsequently, the RPA binds to the 3′ end of the tails, then RPA is displaced by 
RAD51, forming the nucleoprotein filament. Once formed, the complex of Rad51 and 
single-stranded DNA starts to search for a homologous sequence in the double-stranded 
DNA and then promotes invasion of the single-stranded DNA into donor double-
stranded DNA to form a displaced strand (D loop). After strand invasion, a DNA 
polymerase extends the end of the invading 3′ strand by synthesizing new DNA, 
resulting in a change from D-loop to a Holliday junction (HJ) with a cross-shaped 
structure. Finally the HJs are dissolved by BLM/Sgs1 helicase or resolved by one of the 
four resolvases (Mus81-Mms4, Slx1-Slx4, Yen1, and Rad1-Rad10) to yield separate 
intact duplex molecules (Mazon et al., 2010; San Filippo et al., 2008; Svendsen and 
Harper, 2010).  
 
The Ataxia-telangiectasia mutated (ATM) protein may also be linked to HR, as ATM-
deficient mice show severe meiotic disruption (Barlow et al., 1998). Furthermore, the c-
Abl protein-tyrosine kinase which is activated by ATM can modulate Rad51 activity in 
response to DNA damage (Khanna, 2000; Rotman and Shiloh, 1999). ATM also 
phosphorylates selected proteins, including RPA and Brca1, that are linked to HR.  
 
1.1.2.2 Non-homologous end-joining 
NHEJ utilizes little, or no, sequence homology, is often imprecise, functions throughout 
the cell cycle and is considered to be the major pathway for the repair of DSB in 
vertebrate cells (Moore and Haber, 1996; Sonoda et al., 2006). Furthermore, the NHEJ 
pathway is considered as the principle mechanism used during V(D)J recombination 
and CSR (Chaudhuri and Alt, 2004; Jung et al., 2006; Kotnis et al., 2009). The classical 
NHEJ machinery requires a set of proteins, including Ku70, Ku80, DNA-PKcs, DNA 
Lig4, XRCC4, Artemis and the XRCC4-like factor (XLF), also known as Cernunnos.  
 
Once DSBs are introduced, Ku70 and Ku80 form a heterodimer that binds to DNA 
ends and recruit the DNA-PKcs, forming a triad complex termed DNA-PK. DNA-PKcs 
binds and phosphorylates Artemis, activating its DNA end-processing activities. The 
modified DNA ends are then ligated by a complex of DNA Lig4, XRCC4 and 
Cernunnos/XLF (Lieber, 2010; Lieber et al., 2008; Lieber et al., 2003). 
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When one of the NHEJ components is lacking, the damaged DNA ends can still be 
joined via the alternative end joining (A-EJ) pathway, which, however, is not as 
efficient as NHEJ. The Lig4-independent joining pathway and the Ku-independent 
joining pathway that are among the A-EJ pathways that have been described, often use 
a longer microhomology during the repair process (Han and Yu, 2008; Pan-
Hammarstrom et al., 2005; Soulas-Sprauel et al., 2007; Weinstock et al., 2007).  
 
1.2 ANTIBODY DIVERSITY 
The immune system is the body's defense against infectious organisms such as viruses, 
bacteria, pathogenic fungi and parasites. It is a made up of a complex network of cells, 
tissues and organs that protect the body. The innate immune system provides an 
immediate, but non-specific response, whereas the adaptive immune system has the 
ability to recognize pathogens specifically and to provide protection against reinfection 
(Janeway et al., 2005).  
 
There are two major types of lymphocytes in the adaptive immune system: B 
lymphocytes and T lymphocytes. B cells carry cell-surface immunoglobulin molecules 
as receptors for antigens, secrete antibodies that bind antigens, act as antigen-presenting 
cells (APCs) and eventually develop into memory B cells after activation by interaction 
with antigens. T cells have receptors that recognize peptide fragments of intracellular 
pathogens transported to the cell surface by the glycoproteins of the major 
histocompatibility complex (MHC). There are two subsets of T cells (CD8 and CD4) 
that recognize the two classes of MHC molecules (Class 1 and Class 2), respectively 
(Swain, 1983). CD8 T cells kill infected target cells, whereas CD4 T cells mainly 
activate macrophages and B cells (Zamoyska, 1998). 
 
During early T and B lymphocyte development, V(D)J recombination takes place to 
assemble the variable (V) regions of the T cell receptor and Ig genes, respectively, 
giving rise to a large repertoire of antibody specificities (Jung et al., 2006). In B cells, 
two additional mechanisms, which are activated after antigen recognition, further 
diversify the antibody response: class switch recombination and somatic hypermutation 
(Manis et al., 2002b; Papavasiliou and Schatz, 2002). Mechanisms involved in those 
processes will be discussed below. 
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1.2.1 V(D)J recombination 
V(D)J recombination assembles antigen receptor variable region genes from germline 
variable (V), diversity (D) and joining (J) gene segments (Jung et al., 2006). V(D)J 
recombination is initiated by recombination activating gene 1(RAG1) and RAG2 
proteins that are expressed in early B and T cells. RAG1 and RAG2 form a complex 
that bind specifically at recombination signal sequences (RSS). RSS are composed of a 
highly conserved heptamer that resides next to a spacer containing either 12 or 23 
unconserved nucleotides followed by a conserved nonamer (Fugmann et al., 2000). 
RAG proteins recognize the RSS sequences and induce DNA cleavage, following the 
12/23 rule (Eastman et al., 1996; Sawchuk et al., 1997). Then the DNA ends are 
processed and repaired by NHEJ pathway as described above. Terminal 
deoxynucleotidyl transferase (TdT), is another factor involved in V(D)J recombination. 
It can add nucleotides randomly to the DSBs ends, providing additional junctional 
diversities.  
 
The rearrangements occuring in different antigen receptor loci are well-defined, as 
ordered processes. The Ig heavy chain and TCR -chain loci are the first to be 
assembled, with DH to JH joining occurring on both alleles before the initiation of VH 
to DJH joining. Then, recombination of the Ig light chain locus (Ig or Ig) or the TCR 
-chain locus is initiated (Alt et al., 1984). The intergenic control region 1 (IGCR1), 
located between the VH and D clusters, containing two transcriptional repressor CTCF-
binding elements (CBEs), has recently been reported as a key regulatory region 
controlling V(D)J rearrangement (Guo et al., 2011). IGCR1 promotes normal B cell 
development and balances antibody repertoires by inhibiting transcription and 
rearrangement of DH-proximal VH gene segments and promoting rearrangement of the 
distal VH segments (Guo et al., 2011). IGCR1 maintains an ordered and lineage-
specific VH(D)JH recombination by suppressing VH joining to D segments not joined 
to JH segments, and VH to DJH joins in thymocytes, respectively (Guo et al., 2011). 
  
1.2.2 Class switch recombination 
IgM is the first antibody produced by naïve mature B cells. After activation by an 
antigen, these B cells are activated and can switch to produce different antibody 
isotypes. The change in antibody class is effectuated by a deletional recombination 
event called CSR. During CSR, the constant region gene of the  heavy chain (C) is 
14 
replaced by a downstream CH gene (C, C or C) resulting in a change from IgM to 
IgA, IgG or IgE production, without changing the antibody specificity ( Fig. 1) 
(Iwasato et al., 1990; Matsuoka et al., 1990; von Schwedler et al., 1990).  
 
CSR is initiated by activation-induced cytidine deaminase (AID) (Muramatsu et al., 
2000; Revy et al., 2000), which deaminates cytosines to uracils within the switch (S) 
regions (Petersen-Mahrt et al., 2002). Deoxyuridine is removed by uracil-DNA 
glycosylase (UNG), a BER enzyme that generates an abasic site. The latter is then 
recognized by APE1 that creates a nick (Christmann et al., 2003; Rada et al., 2002). 

         V(D)J                  C     C           C3          C1      C             C1   C            C2          C4           C            C2 
 
                      
 
 
 
                                                    
 
 
Figure 1. Deletion model of CSR. In this figure, the C gene is replaced by a C1 gene, resulting in a 
change from IgM to IgA1 production. The intervening sequence is excised as circular DNA and, the S 
and S1 regions are recombined, resulting in a S-S1 recombination junction and a switch to IgA1.  
 
Participation of other enzymes, such as Exo1, may assist in converting the closely 
positioned nicks on both strands into large overlapping gaps, resulting in DSBs. 
In addition, the dU:dG mismatches can be recognized by the MMR proteins and single-
strand nicks may be introduced which eventually leads to the formation of DSBs 
(Stavnezer and Schrader, 2006). Based on the different consequences of UNG 
deficiency, MSH2 deficiency, and UNG-MSH2 double deficiency, the UNG-dependent 
pathway has been suggested to be the major pathway for CSR, whereas the MSH2-
dependent pathway may serve as a backup (Pan-Hammarstrom et al., 2007; Stavnezer 
et al., 2010). 
 
NHEJ is considered to be the principal mechanism used in CSR to repair DSBs, as 
AID-dependent DSBs in S region are introduced and repaired mainly in the G1 phase 
   V(D)J                  C1    C           C2          C4            C            C2 
 S 
 S 
 C 
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 C 
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 S/S1                      S2           S4            S            S2 
S                      S3          S1                         S1                        S2           S4            S            S2 
 Circular DNA 
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of the cell cycle (Schrader et al., 2007). Furthermore, the nature of S region sequences, 
which lacks long stretches of perfect homology between the different S regions, would 
theoretically not support HR (Kotnis et al., 2009). Besides NHEJ factors, there are also 
other DNA repair/damage response factors that have been associated with CSR, such as 
ATM, ataxia-telangiectasia and Rad3-related (ATR), 53BP1 and the MRN complex. 
 
1.2.2.1 ATM and ATR 
ATM and ATR are serine/threonine protein kinase, belonging to the phosphoinositol 3-
kinase-like kinases (PIKKs) superfamily that is involved in cell-cycle control and DNA 
damage responses. ATM phosphorylates several key proteins including NBS1, Mre11, 
H2AX, MDC1 and 53BP1 that initiate activation of the DNA damage checkpoint 
control, leading to cell cycle arrest, DNA repair or apoptosis (Lavin and Kozlov, 2007; 
Shiloh, 2003).  
 
ATM deficiency in humans results in ataxia-telangiectasia (A-T), a rare, multi-system 
disorder which is characterized by cerebellar degeneration with ataxia, telangiectasia, 
chromosomal instability, radiosensitivity and cancer predisposition (Chun and Gatti, 
2004). Most A-T patients have reduced serum levels of IgA, IgE and IgG subclasses 
(Shiloh, 1997). The Sμ-Sα junctions in A-T patients are aberrant, with increased 
microhomology and lack of mutations around the breakpoint, suggesting that ATM is 
involved in the final step(s) in CSR (Pan et al., 2002). ATM-deficient mice have also 
been generated in several laboratories and these mice are characterized by growth 
retardation, infertility, radiosensitivity, defects in T cell maturation and development of 
thymic lymphomas (Barlow et al., 1996; Elson et al., 1996; Xu et al., 1996). Reduced 
levels of switching and increased length of sequence homology in S-S1 junctions 
from ATM-deficient mice further support a role for ATM during CSR (Lumsden et al., 
2004; Reina-San-Martin et al., 2004). 
 
The exact function of ATM during CSR remains unclear. One possibility is that ATM 
recruits and/or activates other DNA-damage response factors, such as X, 53BP1, 
MDC1 and possibly the MRN complex, configuring the DNA termini for subsequent 
repair steps, and/or slowing down cell cycle progression until the repair is complete. A 
second possibility is that ATM may have a more direct role in the end processing step 
through phosphorylation of a proposed nuclease that participates in NHEJ, i.e. Mre11 
or Artemis (Kotnis et al., 2009; Stavnezer et al., 2010). 
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ATR is another member in the PIKKs family, which shares several substrates with 
ATM including H2AX and 53BP1 (Abraham, 2001). Mutations in the ATR gene can 
result in Seckel syndrome, a rare autosomal recessive disorder characterized by 
intrauterine growth retardation, dwarfism, microcephaly, “bird-like” facial features 
and mental retardation (O'Driscoll et al., 2003). Disruption of the ATR gene in mice 
leads to early embryonic lethality (Brown and Baltimore, 2000; de Klein et al., 2000). 
The role of ATR in CSR will be discussed in paper I.  
 
1.2.2.2 NHEJ machinery                                                                                                        
The classical NHEJ machinery requires a number of factors, including Ku70/Ku80, 
DNA-PKcs, DNA Lig4, XRCC4, Artemis and Cernunnos/XLF. All of them have been 
shown to be involved in CSR and will be discussed below.  
 
Ku70/Ku80 
Ku is a heterodimer of Ku70 and Ku80, the first proteins that bind to the DNA ends at a 
DSB. Ku70 or Ku80 knockout mice have severe immunodeficiency and do not develop 
B cells due to defective V(D)J recombination (Gu et al., 1997; Nussenzweig et al., 
1996). Switching in Ku70- or Ku80-deficient B cells from transgenic mice with 
recombined heavy and light chain genes is severely impaired, suggesting that the Ku 
heterodimer is required for CSR (Casellas et al., 1998; Manis et al., 1998). However, 
proliferative defects in the cells make it unclear if Ku has a direct role in end joining 
during CSR through NHEJ (Casellas et al., 1998; Manis et al., 1998; Reina-San-Martin 
et al., 2003). With more optimal activation conditions, Ku70- and Ku80-deficient cells 
have recently been shown to be able to switch, but at a level of 20-50% of wild type 
(WT) cells. The switch junctions obtained from the Ku70-deficient cells presented 
increased microhomolgy and decreased direct joining (Boboila et al., 2010b). 
Moreover, junctions in cells lacking both Ku70 and DNA Lig4 have more direct joins 
than cells lacking DNA Lig4 only, suggesting that Ku still functions at DSBs in DNA 
Lig4-deficient cells and seems to promote microhomology mediated A-EJ at switch 
junctions in the absence of DNA Lig4 (Boboila et al., 2010a; Boboila et al., 2010b).  
 
DNA-PKcs 
Similar to Ku knockout (KO) mice, DNA-PKcs KO mice also require transgenic IgH 
and IgL chains for B cell development. Switching to all Ig classes, except for IgG1, is 
severely impaired in these mice, providing convincing evidence that DNA-PKcs is 
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required for CSR (Manis et al., 2002a). Severe combined immunodeficiency (SCID) 
mice with a natural mutation in DNA-PKcs, lacking kinase activity or the C terminus of 
DNA-PKcs, have also been used in several studies. CSR efficiency was either close to 
normal (Kiefer et al., 2007) or reduced approximately two- to threefold (Bosma et al., 
2002; Cook et al., 2003). The difference between the DNA-PKcs-null and SCID mice 
may suggest that the kinase activity of DNA-PKcs is not essential and might potentially 
be replaced by ATM during CSR (Callen et al., 2009; Shrivastav et al., 2009). In 
addition, DNA-PKcs may have a non-catalytic role in CSR, for instance as a synaptic 
factor, mediating synapse complex formation (DeFazio et al., 2002). 
 
Recently, the first human Radiosensitive (RS)-SCID patient with a DNA-PKcs 
missense mutation (L3062R) was identified (van der Burg et al., 2009). Although the 
patient’s cells show a normal DNA-PK kinase activity, Artemis activation is 
insufficient and B and T cells are almost absent in peripheral blood. CSR from B cells 
in this patient is aberrant and shows a significant increased usage of microhomology at 
S-S junctions (our unpublished data). Although the S-Sjunctions appear to be 
normal, a significant increase of an unusual type of sequential switching from IgM, 
through one IgG subclass, to a different IgG subclass was observed and the S-S 
junctions show long microhomologies (our unpublished data). The altered patterns of 
switch recombination junctions from DNA-PKcs deficient patient further suggest that 
DNA-PKcs may have a non-catalytic role in the NHEJ pathway during CSR. 
 
Artemis 
Artemis can be phosphorylated by several kinases including DNA-PKcs, ATM and 
ATR (Ma et al., 2002; Zhang et al., 2004). It exhibits endonuclease activity on 5′ and 3′ 
overhangs and hairpins when complexed with DNA-PKcs (Ma et al., 2002). It also 
plays an essential role in V(D)J recombination through its activity on opening the 
hairpin structures at the coding ends. In humans, mutations in Artemis result in T- B- 
NK+ SCID associated with increased radiosensitivity, a genetic disorder that is 
characterized by a severe defect in V(D)J recombination leading to an early arrest of 
both B and T cell maturation (Moshous et al., 2001). Hypomorphic mutations in the 
gene have also been described and are associated either with Omenn’s syndrome or 
combined immunodeficiency (CID) (Ege et al., 2005; Evans et al., 2006; Ijspeert et al., 
2011; Moshous et al., 2003). Artemis-deficient B cells that harbored preassembled Ig 
heavy chain and κ-light chain knock-in alleles undergo robust CSR, with normal serum 
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immunoglobulin levels and normal S-S1 junctions, suggesting that Artemis may not 
be involved in CSR (Rooney et al., 2005). However, subsequent studies have shown 
that Artemis is involved: conditional Artemis KO mice show decreased levels of IgA 
expression and reduced CSR to IgG3 accompanied by an increased microhomology 
usage at CSR junctions (Rivera-Munoz et al., 2009). Moreover, B cells from Artemis-
deficient mice generated more AID-dependent IgH locus chromosomal breaks and 
translocations, suggesting that Artemis is necessary for joining AID-dependent DSBs 
during CSR (Franco et al., 2008). The CSR junctions from Artemis-deficient patients 
were also analyzed, and the role of Artemis during CSR is discussed in paper II. 
 
DNA ligase IV and XRCC4 
The X-ray repair cross-complementing protein 4 (XRCC4)-DNA Lig4 complex is 
responsible for catalyzing the ligation step of NHEJ (Lieber, 2010; Lieber et al., 2008). 
Disruption of Lig4 or XRCC4 in mice results in embryonic lethality (Barnes et al., 
1998; Frank et al., 1998; Gao et al., 1998). Patients with hypomorphic mutations have 
been described and they are characterized by microcephaly, growth retardation, 
radiosensitivity and mild to severe immunodeficiency (Buck et al., 2006b; Enders et al., 
2006; O'Driscoll et al., 2001; van der Burg et al., 2006). An altered pattern of CSR 
junctions in B cells was observed in patients with hypomorphic Lig4 mutations, 
characterized by the absence of direct end joining and greatly increased lengths of 
microhomology at the S-S junctions (Pan-Hammarstrom et al., 2005). Xrcc4-/- mice, 
produced by mating xrcc4+/− mice with p53+/− mice, only show 20-50% of normal levels 
of CSR (Soulas-Sprauel et al., 2007; Yan et al., 2007), and the CSR junctions shift 
towards microhomology usage with an absence of direct end joining (Yan et al., 2007). 
Similarly, lack of direct joining and a bias towards a microhomology-based joining 
were observed in DNA Lig4-deficient mouse B cells (Boboila et al., 2010b; Han and 
Yu, 2008). Thus far, XRCC4 and DNA Lig4 are the only proteins required for all 
NHEJ reactions that have no reported roles outside NHEJ (Chaudhuri and Alt, 2004). 
Taken together, the data demonstrate that the classical NHEJ machinery is required for 
CSR, and in its absence, an A-EJ mechanism is operating. 
 
Cernunnos/XLF 
Cernunnos/XLF is a recently identified factor involved in the NHEJ process during 
DNA DSB repair, which stimulates incompatible DNA end ligation by the XRCC4-
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DNA Lig4 complex (Gu et al., 2007; Lu et al., 2007b; Tsai et al., 2007). In humans, 
mutations in the gene encoding Cernunnos result in a rare, autosomal recessive disorder 
with growth retardation, microcephaly, radiosensitivity and CID characterized by a 
profound T and B lymphocytopenia (Buck et al., 2006a). Serum levels of IgG and IgA 
from Cernunnos-deficient patients are low or absent, whereas the level of IgM is 
normal or even high, suggesting a possible role of Cernunnos in CSR (Buck et al., 
2006a). Switching to IgG1 and IgG3 in cultured B cells from Cernunnos deficient mice 
is reduced. The frequency of S-S1 direct joints is reduced, along with a small 
increase in the average length of junctional microhomology, confirming the possible 
role of Cernunnos during CSR (Li et al., 2008). However, only a modestly decreased 
number of mature lymphocytes was observed in those mice and Cernunnos deficient 
pro-B cell lines can support nearly normal levels of V(D)J recombination (Li et al., 
2008). The redundant functional properties of ATM and Cernunnos in joining DNA 
breaks might explain this modest defect of lymphocyte development (Zha et al., 2011). 
If this indeed reflects a lymphocyte-specific compensation for Cernunnos deficiency in 
V(D)J recombination, it is unclear why such a mechanism would not rescue the 
development of T and B lymphocytes in humans. The CSR junctions from Cernunnos-
deficient patients were analyzed, and the potential role of Cernunnos during CSR is 
discussed in paper III. 
 
1.2.2.3 Alternative end-joining pathway 
As discussed above, in the absence of the NHEJ pathway, CSR was still observed at 
low levels suggesting that the A-EJ is operating during CSR. In contrast to NHEJ, the 
mechanism underlying A-EJ is less well-understood. For instance, we still do not know 
the kinetics of the repair, during which part of the cell cycle it is operational, the length 
of the microhomology that is required and whether there is one or multiple pathways 
involved in A-EJ. Several factors have been suggested to be involved in A-EJ during 
CSR, including the MRN complex, Poly (ADP-ribose) polymerase 1 (PARP-1), 
XRCC1 and DNA Lig3 (Kotnis et al., 2009; Robert et al., 2009; Saribasak et al., 2011). 
In a more recent study, cells from a mouse B cell line CH12, with C-terminal binding 
protein-interacting protein (CtIP) knocked down, showed a 40-60% reduction in CSR 
as compared to the control cells, and the S-S junctions were markedly altered, 
characterized by decreased microhomology length and lower frequency of junctions 
with blunt joining (Lee-Theilen et al., 2011). CtIP is thus required for the 
microhomology-dependent A-EJ pathway during CSR (Lee-Theilen et al., 2011). 
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1.2.3 Somatic hypermutation 
Somatic hypermutation (SHM) occurs in the germinal center and is a process where 
point mutations are introduced at a high rate (10-3/basepair/generation (Rajewsky et al., 
1987)) into the Ig variable (V) region genes and which helps to shape the Ig repertoire. 
SHM makes a major contribution to antibody affinity maturation and diversification of 
the antibody repertoire in humans and mice (Milstein and Neuberger, 1996; Rajewsky, 
1996). The generation of mutations starts about 150 bp downstream of the IgV 
promoter and extends over 2 kb, exhibiting decreasing mutation frequency with 
increasing distance from the promoter (Both et al., 1990; Neuberger and Milstein, 
1995; Rajewsky, 1996). During SHM, mutations can occur at all four bases and C/G 
and A/T base pairs are mutated at roughly equal frequencies. However, more mutations 
occur at the A base compared to T base within A/T pairs, whereas, C and G bases 
within C/G pairs are mutated with an almost equal frequency (Golding et al., 1987).  
 
Similar to CSR, SHM is initiated by AID (Muramatsu et al., 2000), which converts 
cytosines to uracils on DNA. AID preferentially deaminates dC in WRCY (where W = 
A/T, R = A/G, and Y = C/T) and the complement RGYW hot-spot motifs during SHM 
(Pham et al., 2003). After deamination by AID, SHM occurs in two phases depending 
on different repair pathways where phase I targets C/G pairs and phase II targets A/T 
pairs. Phase I can be further divided into Ia and Ib (Fig. 2) (Di Noia and Neuberger, 
2007; Liu and Schatz, 2009). 
 
In phase Ia, replication over the uracil results in C to T or G to A transition mutations. 
In phase Ib, uracil is recognized by UNG, generating an abasic site (AP), which can be 
replicated over or repaired in an error-prone manner (possibly by Rev1 or other 
translesion synthesis polymerases (TLS pol)) to give rise to transition/tranversion 
mutations at C/G nucleotides. In phase II, mutations are introduced at adjacent 
positions, predominantly at nearby A/T pairs, mainly through a MSH2/MSH6 
triggered, error-prone, patch repair process. DNA polymerase η clearly plays a major 
role in the introduction of A/T pairs during SHM (Delbos et al., 2005; Martomo et al., 
2005). UNG and Msh2/Msh6 can also act as parts of the normal BER and MMR 
pathways, respectively, resulting in high-fidelity repair of the uracil without mutations 
(Di Noia and Neuberger, 2007; Liu and Schatz, 2009). 
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Figure 2. Repair model for SHM. 
 
It is evident that the BER pathway, operating in SHM, is largely dependent on UNG 
through its uracil excision activity. It is not known, however, which endonuclease acts 
in the step immediately downstream of UNG i.e. that cleaves at the abasic sites 
generated by the latter. Two candidates have been proposed, an AP endonuclease 
(APE) and the MRN complex. The role of the MRN complex during SHM is discussed 
in paper IV. 
 
1.3 GENOMIC INSTABILITY SYNDROMES 
As discussed above, the maintenance of genomic integrity depends on the coordination 
of DNA repair, cell cycle progression, transcriptional and post-transcriptional 
regulation and apoptosis and it requires a variety of different damage response proteins. 
Mutations in the genes that encode these proteins can result in a number of genomic 
instability syndromes or disorders, that often result in a heightened predisposition to 
cancer (Duker, 2002). Immunodeficiency is a hallmark of these disorders, as the ability 
to repair DNA breaks that occur during V(D)J recombination, CSR and SHM are 
critical for the development of the immune system. Several syndromes with defects in 
the DNA DSB response will be discussed below (Table I). 
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1.3.1 Ataxia-Telangiectasia 
Mutations in the gene encoding ATM results in ataxia-telangiectasia (A-T, OMIM 
208900), a rare, multi-system disorder that is characterized by early-onset progressive 
cerebellar ataxia, oculo-cutaneous telangiectasia, immunodeficiency, chromosomal 
instability, radiosensitivity and cancer predisposition (Chun and Gatti, 2004). The 
incidence of the disorder is estimated to be around 1/100.000 live births (Savitsky et al., 
1995). A-T patients are prone to bacterial sinopulmonary infections and pulmonary 
disease is the most common cause of death in A-T patients (Morrell et al., 1986). A-T 
patients show reduced levels of immunoglobulins, where approximately 80% of them 
suffer from IgG2 deficiency and 60% of them have IgA deficiency (Shiloh, 1997). 
Approximately one-third of A-T patients develop malignancies, with lymphomas and 
leukemias of T cell origin being predominant (Peterson et al., 1992). 
 
1.3.2 Seckel syndrome 
Mutations in the gene encoding ATR results in Seckel syndrome (OMIM 210600), an 
autosomal recessive disorder characterized by intrauterine growth retardation and 
postnatal dwarfism with a small head, narrow bird-like face with a beak-like nose, large 
eyes with an antimongoloid slant, receding mandible and mental retardation (Goodship 
et al., 2000; O'Driscoll et al., 2003). Mutations in the genes encoding pericentrin 
(PCNT), Centromere protein J (CENPJ), or Centrosomal protein of 152 kDa (CEP152) 
can also result in Seckel syndrome (Al-Dosari et al., 2010; Griffith et al., 2008; Kalay 
et al., 2011). Thus far, 5 patients from two consanguineous families with Seckel 
syndrome were found to carry mutations in the ATR gene, including a silent 
2101A→G transition in exon 9 that results in increased aberrant splicing, either by 
skipping of exon 9 or by using a cryptic splice donor site within exon 9, both of which 
introduce a frameshift and a stop codon in exon 10 (O'Driscoll et al., 2003). Overt 
immune deficiency is not observed in ATR-Seckel patients. 
 
1.3.3 Severe combined immunodeficiency 
SCID is a severe form of heritable immunodeficiency. Chronic diarrhea, ear infections, 
recurrent Pneumocystis jirovecii pneumonia and profuse oral candidiasis commonly  
occur in SCID patients (Buckley, 2000). There are several forms of SCID. The most 
common type is X-linked SCID which is due to mutations in the gene encoding for the 
common gamma chain of several cytokine receptors, including those for the 
interleukins IL2, IL4, IL7, IL9 and IL15. Other forms of SCID usually follow an 
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autosomal recessive inheritance pattern or are the result of spontaneous mutations in the 
genes including RAG1, RAG2, IL7R, CD45, ADA, JAK3 and Artemis (Haq et al., 2007; 
Kalman et al., 2004; Moshous et al., 2001; Pesu et al., 2005; Sanchez et al., 2007). 
SCID has also classically been divided into patients with residual B cells (T-B+ 
phenotype) and patients who produce neither T nor B cells (T-B- phenotype). A subtype 
of the T-B- phenotype SCID (RS T-B-NK+SCID), has also been described with 
heightened sensitivity to ionizing radiation, where mutations have been observed in 
genes encoding the NHEJ proteins (Nicolas et al., 1998; Schwarz et al., 1996).  
 
Artemis deficiency 
Mutations in the Artemis gene represent the most common cause of RS-SCID, 
characterized by a severe defect in V(D)J recombination leading to an early arrest of 
both B and T cell maturation (Moshous et al., 2001). As of today, more than 100 
patients have been described with various null or hypomorphic mutations in Artemis 
(Darroudi et al., 2007; de Villartay et al., 2009; Ege et al., 2005; Evans et al., 2006; 
Ijspeert et al., 2011; Kobayashi et al., 2003a; Kobayashi et al., 2003b; Lagresle-Peyrou 
et al., 2008; Le Deist et al., 2004; Li et al., 2002; Moshous et al., 2001; Moshous et al., 
2003; Musio et al., 2005; Noordzij et al., 2003; Pannicke et al., 2010; van der Burg et 
al., 2007; van Zelm et al., 2008). 
 
Cernunnos/XLF deficiency 
Mutations in the gene encoding Cernunnos also result in RS-SCID and patients are, 
characterized by growth retardation, microcephaly, radiosensitivity and CID where 
serum levels of IgA and IgG are extremely low or absent, but IgM levels may be 
normal or even high (Buck et al., 2006a). To date, about 10 patients with Cernunnos-
deficiency have been identified, including 3 new patients described in paper III 
(Ahnesorg et al., 2006; Buck et al., 2006a; Turul et al., 2011).   
 
1.3.4 Ataxia-telangiectasia-like disorder  
Defects in MRE11 cause ATLD, another rare autosomal recessive disorder that shares a 
variety of phenotypic similarities with A-T patients, including chromosomal instability 
and radiation sensitivity but no telangiectasia or immunodeficiency (Hernandez et al., 
1993; Klein et al., 1996; Stewart et al., 1999). In contrast to A-T, ATLD is 
characterized by a late onset of the neurological features and a slower progression of 
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Table.1 Genomic instability syndromes 
Defective 
proteins 
Syndrome 
 
Estimated 
Prevalence/ 
No. of patients 
Phenotype 
 
Immunodeficiency 
 
References 
 
 
ATM 
 
Ataxia-
Telangiecta
sia 
 
1:100.000 
 
Ataxia, 
telangiectasia, 
immunodeficiency, 
chromosomal 
instability, 
radiosensitivity, 
cancer. 
 
 
Reduced levels of IgA, 
IgE and IgG subclass, 
Or HIgM 
 
Chun, 2004 
Shiloh, 1997 
ATR Seckel 
syndrome 
NAa/5 Intrauterine growth 
retardation, 
dwarfism with a 
small head, narrow 
bird-like face, 
mental retardation. 
 
No Goodship, 2000 
O'Driscoll, 2003 
Artemis RS-SCID 
CID 
NA/>100 Immunodeficiency, 
radiosensitivity, 
cancer 
Absent or low level of 
IgA and IgG, normal or 
even high level of IgM. 
Moshous, 2001 
et al b. 
Cernunnos RS-SCID 
HIgM 
CID 
 
NA/10 Growth retardation, 
microcephaly, 
radiosensitivity and 
combined 
immunodeficiency. 
Absent or low level of 
IgA and IgG, normal or 
even high level of IgM. 
Ahnesorg, 2006 
Buck, 2006a 
Turul, 2011 
Paper III 
 
 
Mre11 ATLD NA/16 Chromosomal 
instability, 
radiosensitivity, 
cancer. 
 
 
No 
 
Delia, 2004 
Fernet, 2005 
Klein, 1996 
Pitts, 2001 
 
Van der Burgt, 
1996 
et al b. 
 
NBS1 Nijmegen 
breakage 
syndrome 
1:100,000c Microcephaly, 
“bird-like” face, 
growth retardation, 
mental retardation, 
immunodeficiency, 
cancer. 
 
IgA, IgG2, IgG4 
deficiency, 
HIgM 
 
a NA, Prevalence is not analyzed. 
b Additional references are given in the text. 
c 
In Eastern European populations.  
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the disorder, to give the overall appearance of a milder condition than A-T. At present, 
16 ATLD patients have been described (Delia et al., 2004; Fernet et al., 2005; Klein et 
al., 1996; Pitts et al., 2001). 
 
1.3.5 Nijmegen breakage syndrome 
Mutations in the NBS1 gene can cause Nijmegen breakage syndrome (NBS), an 
autosomal recessive chromosomal instability syndrome characterized by microcephaly, 
“bird-like” face, growth retardation, mental retardation, immunodeficiency and 
predisposition to cancer (Carney et al., 1998; Varon et al., 1998). More than 90% of the 
NBS patients showed a 5-bp deletion (657de/ACAAA) in exon 6 of the NBS1 gene. 
Five additional mutations, C>T at 976, 698delAACA, l142delC, 835del-CAGA and 
842insT have been identified in NBS patients (Der Kaloustian et al., 1996; Maraschio 
et al., 2003; Meyer et al., 2004; Saar et al., 1997; Tekin et al., 2002; Tupler et al., 1997; 
van der Burgt et al., 1996; Varon et al., 2000). The frequency of heterozygous carriers 
was estimated at 1/177 in three Slavic populations: Poland, Czech Republic, and 
Ukraine (Varon et al., 2000).   
 
1.4 B-CELL LYMPHOMA 
Lymphoma is a cancer in the lymphatic cells of the immune system. Lymphomas are 
classified into Hodgkin and non-Hodgkin lymphomas (NHL). NHL constitutes around 
90% and Hodgkin lymphoma accounts for the remaining 10% of all lymphomas. Most 
NHL are derived from B (21 sub-types) or T-cells (15 sub-types). The most common 
types of mature B cell lymphomas are follicular lymphoma (FL), diffuse large B cell 
lymphoma (DLBCL), B cell chronic lymphocytic leukaemia/small lymphocytic 
lymphoma (B-CLL/SLL), mucosa-associated lymphoid tissue (MALT) lymphoma, 
mantle cell lymphoma (MCL), marginal zone lymphoma (MZL) and Burkitt lymphoma 
(BL). 
 
A hallmark of mature B cell lymphomas is the presence of chromosomal translocations 
involving the Ig genes and a variety of partner genes. As a result of these translocations, 
oncogenes come under control of Ig gene enhancers and become deregulated (Kuppers 
and Dalla-Favera, 2001; Willis and Dyer, 2000). Translocations may occur at three 
stages in B cell development: V(D)J recombination, CSR and SHM (Kuppers, 2005; 
Kuppers and Dalla-Favera, 2001). Although chromosome translocations are important 
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in B cell lymphomagenesis, they are not sufficient to induce lymphomagenesis. Other 
genetic events are also necessary for lymphoma development and progression.  
 
DLBCL is the most common type of NHL and accounts for 40% of all NHL 
malignancies (Campo et al., 2011). According to gene-expression profiles, overall 
survival rates and response to therapy, DLBCL is classified into three different types: 
germinal B cell like (GCB) DLBCL, activated B cell like (ABC) DLBCL, and primary 
mediastinal B cell lymphoma (PMBL) (Hans et al., 2004; Savage et al., 2003). 
However, 15-30% of DLBCL cannot be classified into any of the above subgroups 
(Alizadeh et al., 2000; Wright et al., 2003). Genetic alterations reported in NHL and in 
DLBCL include chromosomal translocations, mutations caused by aberrant somatic 
hypermutation (ASHM), sporadic somatic mutations and gene copy number alterations 
denoted by deletions and amplifications (Schneider et al., 2011). Known genes that are 
mutated in GCB-DLBCL include BCL2, MYC, EZH2, MLL2, MEF2B, CREBBP/EP30, 
PTEN, PIK3CA, BCL6 and REL. ABC-DLBCL is associated with alteration in genes 
such as TNFAIP3(A20), CARD11, CD79A/CD79B, MYD88, BCL6, PRDM1, BCL2 and 
INK4a/ARF. PMBCL accounts for less than 3% of NHLs and genetic alteration in 
genes such as JAK2, PDL1, PDL2, SOCS1, TNFAIP3 and REL have been observed 
(Schneider et al., 2011). 
 
AID is essential for MYC/IGH translocations in primary B cells and mouse 
plasmacytomas (Kovalchuk et al., 2007; Potter, 2003; Ramiro et al., 2004; Takizawa et 
al., 2008). Knocking out one of the NHEJ factors (DNA Lig4, XRCC4, Ku70, Ku80, 
DNA-PKcs, Artemis or Cernunnos) in mice in a p53 deficiency background leads to 
development of thymic lymphomas or pro-B cell lymphomas associated with complex 
IgH translocations (Difilippantonio et al., 2002; Gladdy et al., 2003; Rooney et al., 
2004; Zhu et al., 2002). These translocations share similar features with the AID 
dependent IgH translocations observed in IL6-induced murine plasmacytomas and are 
likely to be associated with aberrant repair of DSBs during CSR, suggesting a link 
between the NHEJ pathway and aberrant CSR/switch translocations during 
development of B cell malignancies. 
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2 AIMS OF THE PRESENT STUDY 
 
2.1 GENERAL AIM 
The overall aim of this thesis work is to try to understand the mechanisms involved in 
DNA repair during immunoglobulin class switch recombination and somatic 
hypermutation and how these events are involved in the pathophysiological processes 
resulting in immunodeficiency and cancer development in humans. 
 
2.2 SPECIFIC AIMS 
1. Study the CSR and SHM processes in patients with Ataxia-telangiectasia 
related deficiency (paper I). 
2. Study the CSR processes in Artemis deficient patients (paper II). 
3. Study the CSR processes in Cernunnos deficient patients, and its relation to B 
cell lymphomagenesis (paper III). 
4. Study the SHM pattern in patients with Nijmegen breakage syndrome and 
Ataxia-telangiectasia like disorders (paper IV). 
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3 MATERIALS AND METHODS  
The materials and methods are described in detail in each paper. Selected methods are 
discussed below. 
 
3.1 AMPLIFICATION OF SWITCH FRAGMENTS AND ANALYSIS OF THE 
SWITCH JUNCTIONS 
Genomic DNA was purified from peripheral blood lymphocyte (PBL) from patients 
and controls. The amplification of S-S or S-Sfragments from switched cells was 
performed using a nested PCR assay (Pan et al., 2002). Briefly, for amplification of S-
S fragments, the S1 and S-common-1 primers were used in a first PCR run, the 
PCR product was then used as template to perform a second run of PCR with S2 and 
S-common-2 primers (Fig. 3). The number of switch fragments was determined  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Amplification of S-S fragment. The upper part shows the position of primers used, the 
lower part illustrates the nested PCR strategy. 
 
from 10 reactions run in parallel using DNA from one individual and represents 
random amplification of switched clones. PCR products were purified, ligated into the 
pGEM-T vector, transformed into DH5 competent cells and subsequently sequenced. 
The breakpoints were determined by aligning the switch fragment sequences with the 
S (X54713)/S1 (L19121)/S2 (AF030305) or S/S1 (U39737)/S2 (U39934)/ S3 
(U39935) germline sequences. Microhomology was defined as successive nucleotides 
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that were shared by both the S and the downstream S regions (without mismatches). 
Imperfect repeats were determined by identifying the longest overlap region at the S 
junction by allowing one mismatch on either side of the breakpoint. Insertion was 
defined as a nucleotide at the breakpoint that was identical to neither of the S regions. 
Mutation at or close to CSR junctions was defined as a nucleotide change within 15bp 
on both sides of the S junction (Fig. 4). 
 
                  283    Imperfect repeat (9/10 bp)   
                     ▼ 
      S        GAGCTGAGCTGGGCTAAGTTGCACCAGGTGAGCTGAGCTGAGCTGGGCTT 
           
      S-S sequence  GAGCAGAGCTGGGCTAAGTTGCACCAGCTGAGCTGGGCTGACCTGGGCTA 
                    
      S1        GACCTGGGTGAGCTTAAGTGGACTGAGCTGAGCTGGACTGACCTGGGCTA 
                    ▲                  
               1866            
                                 Mutation (>15bp)                 2bp microhomology     Mutation (within 15bp) 
 
 
Figure 4. Determination of switch junctions. The Sand S1 sequences are aligned above and below 
the recombined switch junctional sequences. 2 bp microhomology was indicated by solid-line boxes and 
the imperfect repeats were indicated by dotted-line boxes. The S and S breakpoints for each S 
fragment are indicated by a downward arrowhead and an upward arrowhead, respectively, and their 
positions in the germline sequences are indicated above or below the arrowhead. A nucleotide with green 
color indicates a mutation away from the junction (>15bp) and the red G indicates a mutation close to 
junction (±15bp). 
 
3.2 ANALYSIS OF MUTATION PATTERN IN THE VH TRANSCRIPTS OR JH 
INTRONIC REGIONS  
Total RNA was extracted from patients PBL and first-strand cDNA synthesis was 
performed using a C specific primer. Regions composed of the full V region sequence 
and the V(D)J junctions were PCR amplified using VH3 consensus and C specific 
primers (Fig. 5A). The JH4 intronic regions were amplified from genomic DNA 
prepared from CD27+ B cells using an FR3 consensus primer and a primer upstream of 
JH5 (Fig. 5B) (Faili et al., 2004). 
 
The PCR products were cloned, and sequenced using standard methods. The 
immunoglobulin V(D)J junctional sequences were analyzed by the IMGT/Junction 
Analysis tool (http://imgt.cines.fr) (Fig. 5C) (Giudicelli et al., 2004). The analysis of 
JH4 intronic sequences was performed using the LASERGENE software package. 
Mutations were imported into a Microsoft Excel spreadsheet and computations of the 
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number of each type of nucleotide substitution and the composition of the flanking 
sequences around these substitutions were performed using macros in Excel (methods 
developed by our collaborator Deborah K. Dunn-Walters at the Department of 
Immunobiology, King’s College London School of Medicine, Guy’s Hospital, UK).  
 
A   B 
  
 
VH3 consensus primer           C specific primer                                    FR3 consensus     JH5 specific 
 
C 
 
Figure 5. Amplification the VH transcripts and JH intronic regions and analysis of the mutation 
pattern. (A) PCR strategy for amplification of VH3-C transcripts. (B) PCR strategy for amplification of 
JH4 intronic regions. The arrows indicated the rough positions of the PCR primers used.  (C) Screen snap 
shot for results from the IMGT Analysis tool. 
 
3.3 IN VITRO NHEJ PLASMID ASSAY 
The assay was performed as previously described (Verkaik et al., 2002). Briefly, one 
g of the pDVG94 construct was digested by EcoRV and EcoR47III, resulting in a 
blunt-ended linear joining substrate with a 6-bp direct repeat (ATCAGC) at both ends. 
The linearized plasmids were transiently transfected into fibroblast cell lines using 
TurboFect (Fermentas, Burlington, Ontario, Canada) according to the manufacturer’s 
instruction. During cell culture, the DNA ends could be joined either via direct joining 
or via 6bp-microhomology or other types of joining. Joining via 6bp-microhomology 
can results in the generation of a BstXI restriction site (Fig. 6). Forty-eight hours after 
transfection, plasmid DNA was recovered from the cell lines using the DNeasy blood 
& tissue kit. Recombination junctions were PCR amplified using the primers FM30 and 
DAR5 (Verkaik et al., 2002). The resulting PCR products were gel purified, cloned into 
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pGEM-T vector and sequenced. The percentage of each type of joining used can be 
determined after aligning the sequence with the vector sequences. 
 
   
            
                                           pDVG94 
 
                 
                                            CGACCCAATCAGC           ATCAGCTGGGATC 
                
     
CGACCCAATCAGCATCAGCTGGGATC   CGACCCAATCAGCTGGGATC              CGA---------------------TC              
                                                                      BstXI 
 
 
Figure 6. The NHEJ plasmid assay. The 6-bp direct repeats at the blunt ends are marked with red or 
green color.  
 
In Verkaik et al’s paper, the rejoined fragment was amplified and cut by BstXI. The 
resulted restriction fragments were separated in a 6% polyacrylamide gel and the gel 
was dried on DE-81 paper (Whatman) after electrophoresis and the products were 
visualized by phosphor imaging. Subsequently, the amounts of the undigested and 
digested fragments were quantified using the Image Quant software. However, after 
aligning the recombination junctional sequences, we found that some patient 
(Cernunnos deficient patients) samples show a interesting type of “other types of 
joining”, with a 2-100 bp deletion that are associated with 1-7 bp microhomology 
(exemplified in Fig. 6), which cannot be digested by BstXI (Verkaik et al would 
consider these as “direct joining”). Our data suggest that direct cloning and sequencing 
of the joined fragments may give a better picture of the usage of different types of 
joining (paper III). 
 
 
 
 
 
 
 
 
  direct joining                      microhomology                other types of joining 
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4 RESULTS AND DISCUSSION 
 
4.1 DISPARATE ROLES OF ATR AND ATM IN CSR AND SHM (PAPER I) 
In this paper, we studied the role of ATR during CSR and SHM, showing that ATR has 
a partially overlapping role with ATM during CSR, but also unique functional 
properties in the repair processes during CSR and SHM. 
 
Analysis of CSR in ATRD patients 
DNA from two ATRD patients was used in this study. Thirty nine unique S-
Sjunctions were generated and analyzed. A significantly increased microhomology 
usage was observed, where the average length of overlap was 3.0 ± 3.8 bp, as compared 
to 1.8 ± 3.2 bp in controls (Lahdesmaki et al., 2004; Pan et al., 2002). Interestingly, this 
was mainly because of increased usage of homologies encompassing 4-6 bp, and to a 
much lesser degree due to 1-3 bp homologies. Forty eight S-Sjunctions were also 
generated and analyzed and again the length of microhomology was slightly increased 
(1.8 ± 2.0 bp vs. 1.2 ± 1.2 bp in controls). The number of S junctions with mutations 
was less than in controls in both S-Sand S-Sjunctions whereas insertions were 
observed at a similar rate. 
 
During analysis of CSR junctions, four end joining pathways have been previously 
proposed (Pan-Hammarstrom et al., 2005; Pan et al., 2002). The first is “blunt end” 
joining, where DNA ends are either joined precisely (we later refer that as “direct 
joining”) or where 1-3 bp (mostly 1bp) insertions are introduced. The second pathway 
involves joining of partially complementary “staggered” DNA ends in an imprecise 
process, where mutations are frequently introduced at, or close to, the switch junctions. 
The third pathway exhibits precise joining of complementary DNA ends with a short 
sequence homology (1-3 bp), and no mutations or insertions being introduced at, or 
close to, the junctions. The fourth pathway is an alternative joining where at least 4 bp 
of microhomology is observed at the S junction. The pattern of CSR junctions from 
ATRD patients suggest that ATR is required for processing of partially complementary 
ends as the second pathway is less often used in ATRD patients. The increased usage of 
microhomology of 4-6 bp, but not ≥10 bp, at ATRD CSR junctions also suggest that 
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there may be yet another pathway or subpathway, requiring longer microhomologies     
(≥10 bp), that may be dependent on ATR but not ATM. 
 
Analysis of SHM in ATRD patients 
We subsequently analyzed the SHM pattern in RNA from peripheral blood from three 
ATRD patients. The frequency of mutations in the VH3-23 genes derived from ATRD 
patients varied from 6.8 to 11.9%, which is similar to age-matched control donors. The 
distribution of mutations was also largely similar to the one found in normal controls. 
However, there was a significant difference in the targeting of the A or T nucleotides in 
TA motifs, where the T and A are equally targeted in patients (70 T vs. 69 A mutations, 
respectively), but in controls, A is clearly more targeted (51 T vs. 99 A mutations). 
Interestingly, this biased targeting was most striking in TA motifs within four short 
DNA sequences, which partially overlap with the RGYW motif (underlined) (i.e., two 
are TAGCA and the remaining two are AGCTAT). This suggests that the loss of the A 
preference on the coding strand in ATRD patients might be a result of differences in the 
mechanism generating A/T mutations within these sequences.  
 
As discussed in the SHM section, phase II in SHM is mainly characterized by 
mutations in A-T pairs. The altered SHM pattern in ATRD patients suggests that ATR 
may interact with, or recruit, members of the MMR pathway, such as MSH2, MSH6 or 
polymerase . However, cells deficient in these proteins show reduced rates of 
mutations at both A and T nucleotides (Delbos et al., 2007; Martomo et al., 2004; 
Neuberger et al., 2005), whereas in ATRD cells, the mutation load on A and T 
nucleotides is normal but an increased ratio of T/A targeting is observed. This may 
suggest that ATR is not an “A/T mutator,” but rather, a “recruitor” for “A/T mutators,” 
preferentially to the transcribed strand at specific sequences. ATR and AID can both 
associate with RPA. This may raise the possibility that ATR could be acting as early as 
at the initial AID targeting stage by phosphorylating RPA or by regulating its 
intranuclear translocation (Barr et al., 2003; Bartrand et al., 2004). Alternatively, RPA 
recruits the ATR-ATRIP complex to sites of DNA damage (Zou and Elledge, 2003) 
and ATR involvement could thus be post-initiation. As ATR may be linked to AID via 
RPA and RPA targets AID to SHM hotspots motif (Chaudhuri et al., 2004), it is thus 
logical that the ATR effects are more noticeable near the AID target motifs 
(WRC/GYW). 
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Functional comparison of ATR and ATM in CSR and SHM 
Both ATM and ATR belong to the PIKKs family. The functional roles of ATM and 
ATR have been extensively studied in the general DNA damage response. In vivo 
patterns of CSR junctions and mutations in the VH regions in A-T patients have been 
analyzed previously by our group using a similar experimental design (Pan-
Hammarstrom et al., 2003; Pan et al., 2002). In this study, we have compared the role 
of ATR in CSR and SHM with ATM (Table IV in paper I). In CSR, although they all 
show aberrant S junctions with an increased usage of microhomology and a reduced 
number of mutations/insertions at the S-S junctions, the two characterizations for A-
T patients, i.e., an absence of 0 bp homologies (4.5% in A-T vs. 41.0% in ATRD) and 
an increased proportion of S-S fragments exhibiting ≥10 bp homology (30% in A-T 
vs. 3% in ATRD), were not found in ATRD patients. Another notable difference is that 
the proportion of junctions with insertions was reduced in patients with A-T (2 vs. 25% 
in controls), but not in those with ATRD (23%). In SHM, A-T patients show a normal 
frequency and a largely normal pattern of SHM in the VH regions, whereas in ATRD 
patients, the mutation pattern was clearly altered. These data indicate that the ATM-
dependent pathway is mainly used in the end joining process in CSR, whereas the 
ATR-dependent pathway appears to be involved in both CSR and SHM.  
 
4.2 INVOLVEMENT OF ARTEMIS IN NHEJ DURING CSR (PAPER II) 
Artemis is one of components of the NHEJ pathway. It is essential for V(D)J 
recombination due to its function in opening the hairpin structures at the coding ends 
(Kurosawa and Adachi, 2010; Riballo et al., 2004). It was first thought that Artemis is 
not involved in CSR, as both immunoglobulin levels and S-S1 junctions are normal 
in Artemis deficient mice (Rooney et al., 2005). By analyzing the recombination 
junctions from Artemis-deficient patients, however, our study provides direct evidence 
that Artemis is also required for CSR.  
 
Three RS-SCID patients, who carried different mutations in the Artemis gene, and one 
progressive CID patient with hypomorphic mutations in the Artemis gene were used in 
this study. Lower levels of IgA switching were observed in these patients. Fifty four 
unique S-S junctions were obtained from the patients and were characterized by a 
significantly decreased proportion of junctions with no microhomology (11% vs. 42% 
in controls) and a significantly increased proportion of junctions exhibiting a long 
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microhomology of ≥10 bp (39% vs. 16%). The direct end-joining pathway (no 
microhomology, no insertion) was lacking in these patients, in contrast to the 18% 
observed in age-matched controls. This suggests that in the absence of Artemis, 
recombination of the S and S regions is heavily dependent on the alternative end-
joining pathways that require long microhomologies and the ability of cells to join 
these two S regions by a direct end-joining mechanism appears to be totally lost. The 1-
bp insertion usage and frequency of mutations around the junctions (±15 bp) was 
significantly reduced in Artemis deficient patients, with an altered pattern of insertions 
or mutations, where mainly A/T mutations occurred. These dominant A/T 
mutations/insertions are a unique feature in Artemis-deficient patients as the few 
mutations observed in ATM- or DNA Lig4-deficient patients were mainly located at 
G/C sites (Pan-Hammarstrom et al., 2005; Pan et al., 2002).  
 
S-S junctions could only be amplified from the patient who carried “hypomorphic” 
mutations in Artemis. The junctions appeared to be largely normal, however an unusual 
type of sequential switching was observed (from IgM, through one IgG subclass, to a 
different IgG subclass). The Sx-Sy junctions within the S-Sx-Sy fragments showed 
long microhomologies. Thus, switching to IgG is more affected than switching to IgA 
when the function of Artemis is impaired, as the microhomology-based A-EJ pathway 
cannot be efficiently used as a backup to recombine the S and S regions. This could 
be explained by the fact that the homology between S and Sis much lower than the 
one observed between S and S regions. However, the different Sregions share a 
very high degree of homology and once the switching to IgG3 or IgG1 has occurred, 
the alternative pathway can be used to drive a switch to a downstream IgG subclass, for 
instance IgG2, through a recombination of the two S regions. 
 
Unlike the DH-JH junctions from Artemis deficient cells, where long stretches of 
palindromic nucleotides have been observed (van der Burg et al., 2007), CSR junctions 
in the Artemis-deficient patients showed a normal frequency and length of the potential 
palindromic sequences, suggesting that the hairpin-opening activity of Artemis is 
unlikely to be required for CSR and a hairpin structure is probably not a major 
intermediate during CSR. Based on the pattern of CSR junctions from Artemis 
deficient patients, a possible role of Artemis in direct end joining during CSR is 
proposed. One hypothetical model (Fig. 7, as well as Fig. 3 in paper II) is that Artemis 
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can process a pair of noncompatible ends to one blunt end and one end with 3′ 
overhang. Ku, DNA Lig4/XRCC4, and XLF subsequently promote ligation of such 
modified ends while retaining the 3′ overhang sequence, resulting in no terminal 
microhomology during end joining. A second possibility could be that processing by 
Artemis results in two blunt ends and, subsequently, be directly ligated. Yet another 
possibility could be that Artemis may convert terminally blocked blunt ends with short 
overhangs and ligatable termini (Yannone et al., 2008). It is unclear, however, if such 
blocked blunt ends exist during the CSR reaction. 
 
A 
 
 
 
 
 
 
 
 
 
 
 
 
 
B 
 
Figure 7. Hypothetical model for Artemis-dependent direct end-joining during CSR. The figure 
shows several possible ways of end processing by Artemis that may lead to the precise direct end-joining. 
(A) Possibility 1 is illustrated using the actual sequence of the junction. (B) Schematic models for 
possibilities 1- 4. 
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4.3 ROLE OF CERNUNNOS/XLF DURING CSR AND B CELL 
LYMPHOMAGENESIS (PAPER III) 
Cernunnos is the latest addition to the NHEJ machinery (Ahnesorg et al., 2006; Buck et 
al., 2006a). To investigate whether Cernunnos is required for processing of DSBs 
during CSR, we characterized the S recombinational junctions from Cernunnos 
deficient human B cells. We also screened for somatic mutations in the Cernunnos 
gene in a large cohort of mature B cell lymphomas to address the question whether 
Cernunnos deficiency and aberrant CSR events are associated with development of 
malignancies in mature B cells. 
 
Analysis of CSR in Cernunnos/XLF deficient patients 
Seven Cernunnos deficient patients were used in our study. Serum levels of IgA and 
IgG were markedly reduced in all patients, whereas the levels of IgM were quite 
variable (Table I in paper III) (Buck et al., 2006a; Verloes et al., 2001). Eighty four 
unique S-Sjunctions were analyzed from Cernunnos deficient patients. The average 
overlap is significantly increased in patients (8.5 ± 6.9 vs.3.9 ± 5.1 in controls), mainly 
due to an increased usage of microhomology of ≥10 bp and a significantly decreased 
usage of “direct end joining”. A similar pattern has previously been observed in B cells 
deficient in DNA Lig4, XRCC4, Artemis (paper II), and ATM  (Pan-Hammarstrom et 
al., 2005; Pan et al., 2002; Rivera-Munoz et al., 2009; Yan et al., 2007). The frequency 
of mutations around and away from the junctions (±15 bp) was also significantly 
reduced in patients, with an altered pattern occurring mainly at A/T residues (Table III 
in paper III). 
                                                                                                                                            
In contrast to IgA switching, switching to IgG was more difficult to detect in 
Cernunnos deficient patients. As only 6 S-S junctions could be amplified in spite of 
multiple attempts, a proper comparison with controls was not possible.  
 
The pattern of CSR junctions from Cernunnos deficient patients largely resembles 
those from DNA Lig4, Artemis and ATM deficient patients, suggesting that Cernunnos 
is likely to be involved in the DNA Lig4 dependent NHEJ pathway during CSR. 
Probably, Cernunnos provides end bridging or stability when terminal microhomology 
is absent, and facilitates alignment-based gap filling for partially complementary ends. 
Interestingly, the CSR junctions from patients also show a significantly decreased 
microhomology usage at 1-3 bp, which was not observed in DNA Lig4 deficient cells 
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(Pan-Hammarstrom et al., 2005), suggesting that Cernunnos may have a DNA Lig4 
independent role for ligation of cohesive ends during CSR using few bp 
microhomologies. Recently, Cernunnos has also been suggested to have additional 
roles in the early stages of NHEJ as it quickly responds to DSB induction, can bind to 
DNA (Lu et al., 2007a) and interacts with Ku in a DNA dependent manner (Yano and 
Chen, 2008; Yano et al., 2009; Yano et al., 2008). Taken together, Cernunnos may have 
a number of functions in CSR, both in the early and late steps of DNA Lig4 dependent 
NHEJ, and in some of the DNA Lig4 independent reactions, such as simple re-ligation 
of cohesive ends (the third end-joining pathway discussed in the ATR study). 
 
Role of Cernunnos in B cell lymphomagenesis 
Through screening the Cernunnos encoding gene in 269 mature B cell lymphoma 
samples, a novel missense mutation (p.Q227R), was identified in a Chinese GCB-
DLBCL patient (DL8). The mutation was not identified in 429 ethnically matched 
healthy individuals, suggesting that it does not represent a rare polymorphism in the 
population. Furthermore, by analyzing the microdissected tumor and non-tumor tissues, 
we could confirm that this mutation was somatically acquired in the tumor cells. The 
NHEJ plasmid assay was subsequently used to evaluate if the mutation would affect the 
function of the Cernunnos protein. Our results show that the p.Q227R mutation may 
have a dominant negative effect, where joining of the resected DNA ends, reflected by 
deletions at the junctions, is affected. Translocations in IGH/BCL2 t(14;18)(q32;q21) 
and MYC/IGH t(8;14)(q24;q32) were also identified in 26% and 50% of the cells 
respectively from DL8 based on FISH analysis (Fig. 3C in paper III). A long distance 
PCR assay was subsequently carried out to map the MYC/IGH translocation 
breakpoints, and the results show that the switch γ4 regions may be disrupted, although 
the exact translocation breakpoint could not be mapped. Furthermore, clonal-like, 
dynamic IgA switching activities were observed in these lymphoma cells (Fig. 4 in 
paper III). 
 
Although many studies have provided evidence suggesting a link between NHEJ 
deficiency and B cell lymphomagenesis (Buck et al., 2006b; Gostissa et al., 2011; 
Moshous et al., 2003; Riballo et al., 2001; Zhang et al., 2010), the mutation (p.Q227R) 
observed in our study, represents the first somatically occurring mutation identified in a 
gene encoding a NHEJ factor in human lymphomas. Our study thus suggests a link 
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between Cernunnos deficiency and aberrant CSR/switch translocations during the 
development of B cell malignancies. 
 
4.4 ROLE OF THE MRN COMPLEX DURING SHM (PAPER IV) 
The MRN complex appears to be the major sensor of the DNA breaks and subsequently 
recruits and activates ATM to phosphorylate other proteins which are involved in cell-
cycle control and DNA repair (D'Amours and Jackson, 2002; Lavin and Kozlov, 2007). 
We have previously shown that the MRN complex is involved in CSR (Lahdesmaki et 
al., 2004). To test whether the MRN complex is involved in SHM, we analyzed the in 
vivo SHM patterns in cells from ATLD (Mre11 deficient) and NBS (NBS1 deficient) 
patients. 
 
The SHM pattern in VH3-23-C transcripts was first analyzed in 4 ATLD and 6 NBS 
patients. The frequency and distribution of mutations obtained in both patients groups 
were largely similar to that observed in controls. The mutation pattern observed in cells 
from ATLD patients is largely normal, although a small, but significant, increase in the 
frequency of A to C transversions was observed. These mutations mainly occurred in 
AGA, CAA and CGA, whereas decreased in CTA trinucleotide sequences. These 
trinucleotides are neither related to AID targeting motif nor the SHM hotspot motif. In 
NBS patients, the mutation pattern was altered, with a significantly increased number 
of G transversions (Fig. 1 in paper IV). Unlike ATLD, these G mutations mainly 
occurred in AID hotspot motifs (WRC/GYW) and/or in SHM hotspot motifs for G/C 
mutations (RGYW/WRCY) (Fig. 2 in paper IV). The altered pattern of base pair 
substitutions in NBS patients may thus arise from asymmetric targeting of AID, or 
linked repair steps. 
 
To exclude the possibility that the altered mutation pattern in NBS cells was a result of 
selection bias introduced by studying the expressed VH genes only, the JH4 intronic 
sequences in NBS patients were subsequently analyzed. The mutation pattern in the 
JH4 intronic sequences largely recaptures the features in the VH regions, where an 
increased number of G, but not C, mutations are observed in SHM and/or AID hotspots 
in NBS patients. Although the mutation pattern is altered in NBS patients, the largely 
normal frequency of mutation in both patients groups suggest that the MRN complex is 
not essential for SHM, and Mre11 is thus not likely to be the major nuclear involved in 
cleavage of abasic sites during SHM. 
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The increased frequency of mutations with proportionally more C than G mutations 
was also observed in a human B cell line where the NBS1 gene is overexpressed, 
suggesting that NBS1 may facilitate generation of mutations in the C residues in the top 
strand (Yabuki et al., 2005). However, the results in our study showing a largely normal 
mutation frequency, normal frequency of mutations at the C residues in the top-strand 
hotspot (WRC) and increased number of G mutations in the GYW motifs (AID 
hotspots in the bottom strand), suggest that NBS1 is more likely to influence the 
outcome of deaminated C residues in the bottom strand, rather than to promote 
generation of mutations in the top strand. A hypothetical model for NBS’s function in 
SHM is depicted below (Fig. 8, as well as Fig. 4 in paper IV). 
Figure 8. Hypothetical model for strand-biased mutagenic repair during SHM. 
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5 CONCLUSIONS AND FUTURE PERSPECTIVES 
 
My thesis work was mainly focused on understanding the role of ATR, Artemis and 
Cenunnous during CSR and the function of ATR and the MRN complex during SHM 
process. The main conclusions are: 
 
I. ATR has a partially overlapping role with ATM during CSR. However, ATR 
also has unique functions in the repair process during CSR and SHM. 
 
II. Artemis is required in the predominant NHEJ pathway during CSR. The 
functional role of Artemis in CSR probably relies on its endonuclease activity 
on 3′ or 5′ overhangs, rather than on hairpins. 
 
III. Cernunnos is required in the NHEJ pathway during CSR. The somatic mutation 
identified in the Cernunnos gene in a double hit B cell lymphoma suggests 
linkage of Cernunnos deficiency to aberrant CSR/switch translocations during 
the development of B cell malignancies. 
 
IV. Mre11 is unlikely to be the major nuclease involved in cleavage of abasic sites, 
whereas NBS1 might have an Mre11-independent role in regulating the strand-
specific mutagenic repair process during SHM. 
 
Our present study demonstrates that ATR, Artemis, Cernunnos and the MRN complex 
are involved in the CSR and/or SHM process respectively. However, there are still 
many questions that need to be answered including the components and the mechanism 
of the A-EJ repair pathways. We have established an in vitro cell culture assay that 
allows the analysis of CSR junctions as well as visual identification of class switched 
cells by GFP expression. The naturally CSR deficient Ramos B cell line has been stably 
transfected with plasmids that carry a S region either together with a S2 or a S3 
region (Fig. 9) (constructed in cooperation with Dr. K. Zhang's group (UCLA, USA). 
After cytokine stimulation, switching to IgA2 or IgG3 can be visualized by the 
expression of the excised circular GFP sequence (inverted in the construct). Switch 
junctions also can be analyzed and preliminary results shows the usage of the A-EJ 
with long microhomologies. That makes the transfected Ramos cell lines an ideal 
system to study the factors involved in the A-EJ pathway.  
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               A  
                  pCMV       pI3        SpRSV       IRES-GFP      pSV40      S3      C3        pA 
 
               B 
                  pCMV       pI2        SpRSV       IRES-GFP      pSV40     S2      C2       pA 
 
Figure 9. Structure of switch plasmid. Inverted GFP sequences in plasmid can be expressed with 
promoter SV40 in circular after switch recombination. 
 
The link between defects in the NHEJ pathway and B cell lymphomagenesis also 
requires further experimental support. We are currently performing next-generation 
sequencing in different types of B-cell derived malignancies, to investigate the 
occurrence of genetic alterations in the NHEJ genes. Discovery of such alterations 
could help us understand the pathogenesis of these malignancies as well as aid the 
development of novel and targeted therapeutic strategies. Hopefully, our studies will 
provide a better understanding of B cell development and benefit patients with 
immunodeficiency and/or cancer. 
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